🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
The study will be done in Hacettepe University Anesthesiology and Reanimati...
Status
Unknown
Location
Hacettepe University Hospital
Start Date
2021-01-01
Trial ID
NCT05058716
Treatments Being Tested
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
The purpose of this study is to learn how people with BRCA1/2 mutations res...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2025-09-25
Trial ID
NCT07197723
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a leading global cause of cancer-related ...
Status
Not Yet Recruiting
Location
Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2025-12-31
Trial ID
NCT07350824
Treatments Being Tested
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
This phase II trial evaluates whether early switching from modified fluorou...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2021-05-27
Trial ID
NCT04539808
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
Systemic sclerosis (SSc) is the most severe of the systemic autoimmune dise...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT04986514
Treatments Being Tested
The GLUREDIA study investigates the counter-regulatory response (CRR) durin...
Status
Recruiting
Location
Clinique Universitaires Saint Luc
Start Date
2022-05-25
Trial ID
NCT06770621